Data / Drug companies / Cetirizine hcl
Cetirizine hcl: 48 companies and 98 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Cetirizine hcl is listed in the FDA National Drug Code Directory by 48 companies, with 98 products in commercial distribution. 74 of the products (75.5%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are solution; capsule; tablet, and the newest product started marketing on August 28, 2026.
The request: Get every company that lists cetirizine hcl in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 48
- Products
- 98
- Generic (ANDA) products
- 74 (75.5%)
- Application numbers
- 11
- Routes
- Oral
- Brand names
- Allergy Relief, All Day Allergy Relief, Good Sense Childrens All Day Allergy, Childrens Cetirizine Hydrochloride, Childrens Allergy Relief, Childrens All Day Allergy, Childrens All Day Allergy, Childrens Dye Free Allergy Relief
- openFDA record search
- api.fda.gov
Companies that list cetirizine hcl
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| CVS Woonsocket Prescription Center, Incorporated | 5 | capsule; tablet | Generic drugs (ANDA) | August 24, 2026 |
| Dolgencorp, Inc. (dollar General & Rexall) | 5 | tablet; capsule | Generic drugs (ANDA) | November 25, 2024 |
| Kroger Company | 5 | solution; capsule | Generic drugs (ANDA) | April 27, 2026 |
| Pioneer Life Sciences, LLC | 5 | tablet | Generic drugs (ANDA) | April 6, 2026 |
| Amazon.com Services LLC | 4 | solution | Generic drugs (ANDA) | August 12, 2026 |
| Topco Associates LLC | 4 | capsule; solution | New drug applications (NDA) | May 30, 2026 |
| American Sales Company | 3 | solution; capsule, liquid filled | Generic drugs (ANDA) | December 31, 2024 |
| Amerisource Bergen | 3 | capsule; solution | New drug applications (NDA) | May 30, 2026 |
| Meijer, Inc. | 3 | capsule; tablet | New drug applications (NDA) | May 1, 2026 |
| P & L Development, LLC | 3 | capsule; tablet | Generic drugs (ANDA) | May 28, 2021 |
| Preferred Pharmaceuticals Inc. | 3 | solution | Generic drugs (ANDA) | March 17, 2026 |
| Strategic Sourcing Services LLC | 3 | tablet; solution | Generic drugs (ANDA) | September 20, 2023 |
| Walgreen Company | 3 | capsule; tablet | New drug applications (NDA) | May 25, 2026 |
| Walmart Inc. | 3 | capsule, liquid filled; capsule | Generic drugs (ANDA) | March 31, 2025 |
| Bionpharma Inc. | 2 | capsule | New drug applications (NDA) | May 25, 2026 |
| CVS Pharmacy | 2 | solution | Generic drugs (ANDA) | September 22, 2015 |
| Cardinal Health 110, LLC. DBA Leader | 2 | solution | Generic drugs (ANDA) | February 28, 2017 |
| HyVee Inc | 2 | solution | Generic drugs (ANDA) | March 20, 2016 |
| L. Perrigo Company | 2 | solution | Generic drugs (ANDA) | January 11, 2016 |
| Medline Industries, LP | 2 | tablet, film coated; tablet | Generic drugs (ANDA) | August 28, 2026 |
| Meijer Distribution Inc | 2 | solution | Generic drugs (ANDA) | May 22, 2018 |
| Nuvicare LLC | 2 | tablet | Generic drugs (ANDA) | June 9, 2025 |
| Publix Super Markets Inc | 2 | capsule | New drug applications (NDA) | July 15, 2026 |
| Rite Aid Corporation | 2 | solution | Generic drugs (ANDA) | June 23, 2022 |
| Target Corporation | 2 | capsule | New drug applications (NDA) | December 9, 2025 |
| United Natural Foods, Inc. DBA Unfi | 2 | capsule; solution | New drug applications (NDA) | January 15, 2019 |
| A-S Medication Solutions | 1 | solution | Generic drugs (ANDA) | January 11, 2016 |
| Atlantic Biologicals Corp. | 1 | solution | Generic drugs (ANDA) | August 22, 2018 |
| Bryant Ranch Prepack | 1 | tablet | Generic drugs (ANDA) | December 31, 2018 |
| Camber Consumer Care Inc | 1 | tablet | Generic drugs (ANDA) | December 31, 2018 |
| Chain Drug Marketing Association | 1 | capsule | New drug applications (NDA) | January 25, 2019 |
| Costco Wholesale Company | 1 | solution | Generic drugs (ANDA) | July 8, 2016 |
| Discount Drug Mart | 1 | capsule | New drug applications (NDA) | August 2, 2019 |
| Family Dollar (family Wellness) | 1 | tablet | Generic drugs (ANDA) | July 1, 2023 |
| Famora Inc. | 1 | tablet, coated | Generic drugs (ANDA) | March 18, 2026 |
| H E B | 1 | capsule | Generic drugs (ANDA) | October 15, 2021 |
| Hart Health | 1 | tablet | Over the counter monograph drugs | August 4, 2025 |
| Major Pharmaceuticals | 1 | solution | Generic drugs (ANDA) | August 22, 2018 |
| New World Imports, Inc | 1 | tablet | Generic drugs (ANDA) | December 7, 2023 |
| Northeast Pharma | 1 | capsule | New drug applications (NDA) | September 26, 2023 |
| Precision Dose, Inc. | 1 | solution | Generic drugs (ANDA) | October 26, 2016 |
| Proficient Rx LP | 1 | solution | Generic drugs (ANDA) | August 22, 2018 |
| Retail Business Services, LLC | 1 | capsule | Generic drugs (ANDA) | April 30, 2018 |
| Safeway | 1 | capsule | Generic drugs (ANDA) | October 15, 2021 |
| The Kroger Co. | 1 | capsule | New drug applications (NDA) | May 25, 2026 |
| Wal-Mart Stores Inc | 1 | capsule | Generic drugs (ANDA) | March 31, 2018 |
| Whole Foods Market, Inc. | 1 | capsule | New drug applications (NDA) | December 9, 2025 |
| WinCo Foods, LLC | 1 | tablet | Generic drugs (ANDA) | January 15, 2020 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Solution | 37 | 37.8% |
| Capsule | 32 | 32.7% |
| Tablet | 23 | 23.5% |
| Capsule, liquid filled | 4 | 4.1% |
| Tablet, film coated | 1 | 1% |
| Tablet, coated | 1 | 1% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 74 | 75.5% |
| New drug applications (NDA) | 23 | 23.5% |
| Over the counter monograph drugs | 1 | 1% |
Pharmacologic classes
| Class | Products |
|---|---|
| Histamine-1 Receptor Antagonist | 98 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.